Blood collection methods could make or break cancer detection

NCT ID NCT05945290

Completed Knowledge-focused Sponsor: Mayo Clinic Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study looked at how the way blood samples are collected and processed affects the ability to detect tumor DNA in women with early-stage breast cancer. Researchers tested different collection tubes, processing speeds, and storage conditions to see which methods preserve tumor DNA best. The goal is to improve the accuracy of liquid biopsies for cancer monitoring.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this research could improve how doctors collect and handle blood samples to better detect tumor DNA in breast cancer patients.
What could go wrong: This is an observational study focused on lab methods, not a treatment. It will not directly improve patient outcomes and results may not apply to all settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANATOMIC STAGE I BREAST CANCER AJCC V8 are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ANATOMIC STAGE I BREAST CANCER AJCC V8 ANATOMIC STAGE II BREAST CANCER AJCC V8 ANATOMIC STAGE III BREAST CANCER AJCC V8 EARLY STAGE BREAST CARCINOMA LOCALLY ADVANCED BREAST CARCINOMA

Blood collection methods could make or break cancer detection

Summary

What this could mean

Get notified about this study

Conditions

As listed by the trial registrant

Contacts and locations

Locations

More trials for these conditions